Stock listing

B3:BIOM3 Biomm SA Ações

Home listing (B3) of Biomm SA

Follow Biomm SA into a list and get an email when it puts out news.

Share price · BMFBOVESPA:BIOM3

5.33 BRL -0.35 (-6.2%)

Close on Nov 19, 2026

Past year -28.9% · daily closes, Nov 19, 2025 – Nov 19, 2026, adjusted for splits
Day range
5.33 – 5.82 BRLNov 19, 2026
Volume
264,100 sharesNov 19, 2026
Market cap
729.4M BRLAt the close on Nov 19, 2026 · price × 136.9M shares outstanding
52-week range
4.81 – 9.75 BRLLowest and highest trades, Nov 21, 2025 – Nov 19, 2026
Traded on an average day
390,948 BRLMedian day 40,300 shares · last 3 months, Aug 19, 2026 – Nov 19, 2026
Biomm SA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
B3:BIOM3 · Home5.33 BRL-0.35 (-6.2%)264,1005.805.825.335.68Close on Nov 19, 2026

Daily closes

Last 3 months, Aug 19, 2026 – Nov 19, 2026 · BMFBOVESPA:BIOM3 · BRL, adjusted for splits

DayCloseChange%OpenHighLowVolume
5.33-0.35-6.2%5.805.825.33264,100
5.68+0.13+2.3%5.405.895.40211,000
5.55-0.45-7.5%5.725.875.55140,300
6.00+0.54+9.9%5.546.005.5415,200
5.46-0.38-6.5%5.846.005.4634,600
5.84+0.62+11.9%5.425.905.2680,500
5.22-0.64-10.9%5.875.874.81233,700
5.86-0.07-1.2%5.815.875.8011,800
5.93+0.43+7.8%5.845.945.6186,400
5.50-0.83-13.1%6.296.505.50123,000
6.33+1.28+25.3%5.326.335.14119,300
5.05-0.25-4.7%5.295.455.0019,800
5.30-0.05-0.9%5.415.485.3017,500
5.35+0.02+0.4%5.555.555.3537,200
5.33-0.19-3.4%5.615.615.3241,300
5.52+0.07+1.3%5.755.895.5050,000
5.45-0.45-7.6%5.705.805.41140,400
5.900.000.0%6.006.105.90156,900
5.90-0.06-1.0%6.006.025.9040,300
5.96-0.37-5.8%6.136.205.9626,600
6.33+0.35+5.9%6.006.335.9425,700
5.98+0.08+1.4%5.996.185.9447,600
5.90-0.20-3.3%6.096.145.9096,000
6.10-0.21-3.3%6.236.235.90120,800
6.31-0.30-4.5%6.536.636.3179,100
6.61-0.73-9.9%7.157.336.6165,300
7.34+0.25+3.5%7.157.607.14134,800
7.09+0.19+2.8%6.947.106.9071,100
6.90+0.04+0.6%6.857.106.63184,700
6.86+0.42+6.5%6.436.866.43119,600
6.44-0.01-0.2%6.567.406.4088,100
6.45+0.39+6.4%6.126.455.9657,300
6.06-0.04-0.7%6.116.155.8646,800
6.10+0.22+3.7%5.906.105.8155,200
5.88-0.10-1.7%6.046.295.7739,600
5.98-0.15-2.4%5.946.295.71127,700
6.13+0.13+2.2%5.916.205.9121,500
6.00-0.26-4.2%6.296.296.0027,200
6.26-0.15-2.3%6.426.446.265,200
6.41-0.06-0.9%6.466.476.382,900
6.47+0.21+3.4%6.296.476.2911,800
6.260.000.0%6.356.366.2637,100
6.26-0.35-5.3%6.566.566.26195,700
6.61+0.11+1.7%6.516.736.4322,500
6.50-0.03-0.5%6.556.696.4820,600
6.53-0.17-2.5%6.706.706.521,600
6.70+0.12+1.8%6.536.786.5351,100
6.58+0.02+0.3%6.536.746.4789,500
6.56-0.23-3.4%6.636.776.5324,200
6.79+0.16+2.4%6.546.806.549,800
6.63+0.21+3.3%6.376.636.3722,300
6.42-0.03-0.5%6.466.466.413,300
6.45+0.28+4.5%6.346.456.2931,000
6.17-0.10-1.6%6.496.496.175,600
6.27-0.07-1.1%6.376.506.2010,800
6.34-0.02-0.3%6.386.456.1122,300
6.36-0.08-1.2%6.646.646.3610,200
6.44-0.33-4.9%6.636.636.4411,700
6.77+0.17+2.6%6.796.796.3291,000
6.600.000.0%6.506.786.2770,500
6.60+0.48+7.8%6.166.606.1626,200
6.12-0.28-4.4%6.416.426.0317,300
6.40-0.10-1.5%6.486.506.303,200
Ticker
B3:BIOM3
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
B3
Currency
BRL

What changed lately

Latest news

All Biomm SA news

Biomm SA on 6ix

Sector
Health care
Industry
Biotechnology
News releases
1 in the last 12 months · 2 in all · newest Nov 24, 2025 · oldest 2025

Where Biomm SA is listed

ListingExchangeCountryCurrency
B3:BIOM3 · Home listing · This pageB3BrazilBRL
B3:BIOM3FB3BrazilBRL

Valuation

EV/sales 2.1× against a median of 26.7×: 3rd lowest of 7 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 19, 2026

Enterprise value
812.0M BRL
P/E
18.4×
EV/sales
2.1×
EV/EBITDA
12.3×
Price/book
2.2×
Gross margin
35.4%
Operating margin
13.8%
Net margin
10.3%
Debt to equity
0.3×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Biomm SA · BMFBOVESPA:BIOM3US$123.5MUS$137.5M18.4×2.1×12.3×2.2×10.3%0.3×n/a
Yoda Pharmaceuticals Inc. · TPEX:7829US$127.1MUS$94.39Mn/an/an/a3.9×n/a0.0×n/a
UnicoCell Biomed Co., Ltd. · TWSE:6794US$126.3MUS$106.5Mn/a117×n/a5.1×−381.5%0.1×n/a
MacroGenics, Inc. · NASDAQ:MGNXUS$125.3M−US$127.6Mn/a−0.9×n/a5.0×−34.6%1.4×0.83
PolyPid Ltd. · NASDAQ:PYPDUS$124.3MUS$119.3Mn/an/an/a23.1×n/a0.3×0.93
Compass Therapeutics, Inc. · NASDAQ:CMPXUS$123.9M−US$29.89Mn/an/an/a0.9×n/a0.1×1.22
Humacyte, Inc. · NASDAQ:HUMAUS$123.7MUS$96.01Mn/a40.1×n/a6.8×n/a2.0×2.56
Invivyd, Inc. · NASDAQ:IVVDUS$122.0MUS$3.86Mn/a0.1×n/a0.8×−214.8%0.1×2.06
Satellos Bioscience Inc · TSX:MSCLUS$121.9MUS$69.24Mn/an/an/a2.5×n/a0.0×0.49
Alar Pharmaceuticals Inc · TPEX:6785US$121.0MUS$51.67Mn/a568×n/a1.7×n/a0.0×n/a
CANbridge Pharmaceuticals Inc. · HKEX:1228US$120.4MUS$111.5Mn/a13.4×n/an/a−146.4%n/an/a
Median of the othersUS$123.8MUS$81.81M26.7×3.9×−180.6%0.1×1.08

Team and board

Officers

OfficerRole
Guilherme MaradeiChief Executive Officer
Marclo Sáfadi AlvaresChief Financial and Investor Relations Officer
Alexandre Bernardes GonçalvesCommercial Director
André Capistrano EmrichMember of the Executive Committee
Anna Emilia Sousa Leite GaetaniManager
Davi KhattarManager
Francisco Carlos Marques de FreitasChief Technology Officer

Board

DirectorRole
Cláudio Luiz LottenbergChairman of the Board
André Capistrano EmrichMember of the Executive Committee
Walfrido Silvino dos Mares Guia NetoVice Chairman of the Board

Financials

Annual, in BRL

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue269.3M142.9M118.2M105.0M107.1M58.7M8.94M1.57M103.0K0
Cost of revenue187.5M125.0M94.9M89.0M80.2M44.7M8.42M1.32M67.0K420.0K
Gross profit81.8M17.9M23.3M16.0M26.9M13.9M521.0K245.0K36.0K-420.0K
Research and development4.46M4.38M
Selling, general and administrative48.2M49.7M48.1M50.2M47.3M35.4M32.2M32.6M31.2M27.4M
Operating income4.83M-81.2M-72.5M-86.2M-65.6M-55.4M-52.6M-36.7M-35.4M-30.6M
Depreciation and amortization8.57M11.9M11.5M12.3M11.6M10.5M4.62M1.74M495.0K420.0K
EBITDA13.4M-69.3M-61.0M-74.0M-54.0M-44.9M-48.0M-34.9M-34.9M-30.2M
Interest expense13.1M12.9M15.0M16.8M17.3M14.1M12.6M19.3M16.2M6.00M
Income before tax-6.95M-76.6M-80.8M-93.2M-79.8M-70.7M-55.8M-42.5M-41.0M-50.0M
Income tax-261.0K644.0K340.0K-630.0K475.0K63.0K38.0K33.0K-2.90M-4.41M
Net income-6.69M-77.2M-81.1M-92.6M-80.3M-70.8M-55.8M-42.6M-38.1M-45.6M
Earnings per share, basic-0.05-0.63-0.98-1.26-1.15-1.12-1.11-0.97-1.10-1.42

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents22.3M77.6M26.0M75.9M31.4M57.4M30.1M21.0M8.63M7.83M
Short-term investments20.9M65.8M27.7M28.6M23.8M84.7M74.6M67.0M32.5M30.7M
Receivables124.5M22.9M26.4M25.5M27.6M20.5M4.96M622.0K66.0K410.0K
Inventory97.3M55.0M47.0M42.4M49.9M18.5M23.6M16.9M16.4M12.2M
Current assets281.1M242.1M128.3M183.5M141.8M200.9M148.1M109.9M64.4M51.5M
Property, plant and equipment163.8M167.6M165.7M163.8M163.2M159.8M161.6M156.3M155.7M95.4M
Goodwill245.0K
Total assets524.2M465.7M344.7M405.1M369.8M435.0M388.8M305.7M262.4M237.4M
Accounts payable66.6M32.2M27.7M34.0M17.7M11.3M39.4M18.9M18.0M11.5M
Current liabilities126.2M88.9M84.2M92.5M78.7M66.3M60.8M41.3M43.3M19.7M
Long-term debt50.9M76.9M105.9M121.2M134.1M144.7M142.8M130.7M134.8M113.1M
Total debt96.6M121.4M153.6M172.3M184.1M188.3M155.6M147.3M155.0M117.2M
Total liabilities210.7M202.9M221.8M246.0M258.2M243.5M235.2M199.6M203.1M171.5M
Shareholders' equity313.5M262.8M122.9M159.1M111.6M191.5M153.6M106.1M59.3M65.9M
Shares outstanding129.4M122.2M83.2M73.7M70.1M63.2M50.4M44.0M34.6M32.1M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-111.9M-91.8M-74.8M-63.0M-93.8M-96.9M-77.6M-44.1M-54.4M-38.3M
Capital spending-26.6M-19.2M-6.22M-5.44M-7.44M-4.63M-7.35M-909.0K-5.81M-63.2M
Free cash flow-138.5M-111.0M-81.0M-68.4M-101.2M-99.9M-88.2M-47.1M-60.2M-101.4M
Cash from investing22.4M-38.0M-2.86M-6.16M61.5M-6.84M-20.5M-27.3M-2.16M-21.7M
Cash from financing34.2M180.9M25.6M113.8M7.42M129.2M107.4M80.5M57.4M42.8M
Share buybacks57.5M217.0M45.0M128.3M0107.3M100.0M89.3M27.6M27.6M
Change in cash-55.3M51.6M-49.9M44.6M-26.0M27.3M9.09M12.4M797.0K-17.2M

Open Financials

Cap table

Built by 6ix from Biomm SA’s releases

Common shares
136,852,484
Fully diluted
136,852,484

Fully diluted

LineShares
Common shares136,852,484

Share count over time

CountShares
Nov 22, 2026136,852,484

Open Cap table

Shareholders

HolderSharesOf the companyAs of
Alaska Investimentos Ltda.35.8M26.2%May 4, 2026
BTG Pactual Gestão e Consultoria de Investimentos Ltda.16.7M12.2%May 4, 2026
Walfrido Silvino Dos Mares Guia Neto7.56M5.5%Jan 6, 2026
Tmg/Ibr L.P.7.44M5.4%Jul 28, 2025
Bndespar7.01M5.1%Apr 10, 2025
Italo Aurelio Gaetani4.32M3.2%May 4, 2026
Samos Participações Ltda.3.71M2.7%Aug 28, 2025
Tmg/Ibr L.P.2.47M1.8%Apr 10, 2025
Gama Participações Ltda.2.08M1.5%Oct 28, 2024
Elbrus Participações Ltda.575K0.42%Oct 10, 2023

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Alexandre Bernardes GonçalvesCommercial Director · Since at least Nov 5, 2026
André Capistrano EmrichMember of the Executive Committee · Since at least Nov 5, 2026
Anna Emilia Sousa Leite GaetaniManager · Since at least Nov 5, 2026
Cláudio Luiz LottenbergChairman of the Board · Since at least Nov 5, 2026
Davi KhattarManager · Since at least Nov 5, 2026
Francisco Carlos Marques de FreitasChief Technology Officer · Since at least Nov 5, 2026
Guilherme MaradeiChief Executive Officer · Since at least Nov 24, 2025
Marclo Sáfadi AlvaresChief Financial and Investor Relations Officer · Since at least Nov 5, 2026
Walfrido Silvino dos Mares Guia NetoVice Chairman of the Board · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Biomm SA.